Skip to main content

Table 4 Cell culture performance comparison between fed-batch Process C and Process A or B for different mAb production on Day 14 unless otherwise specified

From: Development of an intensified fed-batch production platform with doubled titers using N-1 perfusion seed for cell culture manufacturing

Product

Process at bioreactor scale

Titer (normalized weight/L)

Peak VCD (× 106 cells/mL)

Cell specific productivity (normalized weight/cell/day)

Volumetric productivity (normalized weight/L/day)

mAb1

B at 1000-L (n = 5)

0.5 ± 0.03

24.0 ± 2.7

2.05 ± 0.20

0.035 ± 0.002

C at 500-L (n = 2)

1.00 ± 0.02

29.7 ± 1.3

2.98 ± 0.06

0.071 ± 0.002

mAb2 on Day 10

B at 1000-L (n = 5)

0.50 ± 0.02

19.5 ± 1.1

3.03 ± 0.21

0.042 ± 0.002

C at 5-L (n = 4)

1.00 ± 0.01

33.4 ± 1.6

3.04 ± 0.07

0.084 ± 0.001

mAb3

B at 1000-L (n = 3)

0.53 ± 0.02

22.3 ± 0.3

2.24 ± 0.05

0.034 ± 0.000

C at 500-L (n = 2)

1.00 ± 0.05

40.9 ± 5.0

2.41 ± 0.36

0.071 ± 0.001

mAb4

A at 1000-L (n = 5)

0.31 ± 0.03

32.9 ± 2.7

1.05 ± 0.14

0.022 ± 0.002

C at 5-L (n = 4)

1.00 ± 0.02

42.3 ± 1.3

2.28 ± 0.08

0.071 ± 0.002

C at 500-L on Day 12 (n = 1)

1.00

47

2.24

0.083

  1. The Process C final titer at 500-L scale was normalized as 1 for each of mAb1, mAb3 and mAb4, while the Process C titer at 5-L scale on Day 10 was normalized as 1 for mAb2